NCT02964078 2026-04-02Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed27 enrolled 10 charts
NCT05935748 2025-11-12Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)NiKang Therapeutics, Inc.Phase 2 Terminated18 enrolled